Related references
Note: Only part of the references are listed.Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy
Michele Ciabatti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
Razvan Capota et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition
Gregor Andelfinger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Hypertrophic Cardiomyopathy
Jeffrey B. Geske et al.
JACC-HEART FAILURE (2018)
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Carolyn Y. Ho et al.
CIRCULATION (2018)
Women with hypertrophic cardiomyopathy have worse survival
Jeffrey B. Geske et al.
EUROPEAN HEART JOURNAL (2017)
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Ethan J. Rowin et al.
CIRCULATION (2017)
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality Shaped by 50 Years of Clinical Research and Practice
Barry J. Maron et al.
JAMA CARDIOLOGY (2016)
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High-Risk Population
Konstantinos C. Siontis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Hypertrophic cardiomyopathy
Barry J. Maron et al.
LANCET (2013)
Share Paper
